Patent · US Active

CD137 binding fibronectin type III domains

US11345739B2 · kind B2 · utility

1Cited by

54References

20Claims

0Family size

Assignee

JANSSEN BIOTECH, INC. · US

Inventors

Michael Diem · Havertown, US
Rebecca Hawkins · Harleysville, US
Steven Jacobs · North Wales, US
Manuel Sepulveda · Princeton Junction, US

Key dates

Filing date	Mar 17, 2020
Grant date	May 31, 2022
Priority date	—
Expiry date	Mar 27, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/40
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

FN3 domains that specifically bind to CD137, their conjugates, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making and using them are useful in therapeutic and diagnostic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.